Translational Adult Glioma Grant

The Ben and Catherine Ivy Foundation holds a strong set of values that clearly guides all funding decisions in order to fulfill our mission of helping patients with brain tumors.

• We uphold the highest standards and expect our grant recipients to do the same.

Ivy Foundation Translational Adult Glioma Grant Award

The Ben & Catherine Ivy Foundation Emerging Adult Glioma Award provides grant support to investigators conducting high-impact, high-reward translational research for glioblastoma.  This award is intended to support projects designed to contribute to identifying therapies that will impact the survival of patients with brain cancer.

Award Terms

• $600,000 total, payments received at initiation and completion of project
• Project duration is 24 months
• The proposal milestones are to be completed within the two year award timeline
• Indirect costs not to exceed 10% (included in award total-$60,000 maximum)
• One Principal Investigator allowed; Co-Investigators permitted (only one position allowed per year)
• No Cost Extensions are not permitted by contract

Eligibility

_You can learn more about this opportunity by visiting the funder's website._

• Eligibility
  • A PhD, MD or equivalent is required.
  • Only one submission per applicant is permitted every calendar year, as PI and or CO Investigator.
  • Applicants need not be U.S. citizens, but must be employed by a U.S. non-profit academic institution.
  • The Ben & Catherine Ivy Foundation does not discriminate on the basis of race, color, religion, national origin, sex, gender identity, sexual orientation, age, disability or any other legally protected characteristics.
  • Clinical trials eligible
• Applicants must have a faculty appointment as an independent investigator.

Ineligibility

• Travel expenses excluded.
• BioTech companies are ineligible.